A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Hepatitis B vaccine (Primary) ; ADVAX; Hepatitis B vaccine recombinant
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Acronyms HBV003
- Sponsors Vaxine
- 10 Oct 2018 Planned initiation date changed from 1 Jun 2018 to 1 Dec 2018.
- 04 May 2018 Planned End Date changed from 1 Mar 2019 to 1 Dec 2020.
- 04 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2019.